Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Murray

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 8, 2018
Long-term hypoxia uncouples Ca<sup>2+</sup> and eNOS in bradykinin-mediated pulmonary arterial relaxationCarla Blum-Johnston, Richard B Thorpe, Chelsea Wee, et al.
Journal of Clinical Pathology|July 12, 2014
Guidance for laboratories performing molecular pathology for cancer patientsIan A Cree, Zandra Deans, Marjolijn J L Ligtenberg, et al.
Journal of Oncology|January 13, 2010
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck CancerGeorge Fountzilas, Anna Kalogera-Fountzila, Sophia Lambaki, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 26, 2025
Development of a preclinical model of ICU-associated sleep fragmentation and effects on pneumonia recovery in miceMahendra Damarla, Karthik Suresh, Linda Zheng, et al.
Journal of Clinical Medicine|August 6, 2020
Predicting the Role of DNA Polymerase β Alone or with <i>KRAS</i> Mutations in Advanced NSCLC Patients Receiving Platinum-Based ChemotherapyMaria Francesca Alvisi, Monica Ganzinelli, Helena Linardou, et al.
Cancer|September 25, 2020
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trialDarren R Feldman, Yasser Ged, Chung-Han Lee, et al.
Biomarkers in Medicine|July 28, 2017
RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world dataGeorge Kafatos, Daniela Niepel, Kimberley Lowe, et al.
JCO Precision Oncology|July 7, 2022
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell CarcinomaRitesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 16, 2024
Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertensionNicolas Philip, Xin Yun, Hongyang Pi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2021
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell CarcinomaJack P Gleeson, Ines Nikolovski, Renzo Dinatale, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 8, 2018
Long-term hypoxia uncouples Ca<sup>2+</sup> and eNOS in bradykinin-mediated pulmonary arterial relaxationCarla Blum-Johnston, Richard B Thorpe, Chelsea Wee, et al.
Journal of Clinical Pathology|July 12, 2014
Guidance for laboratories performing molecular pathology for cancer patientsIan A Cree, Zandra Deans, Marjolijn J L Ligtenberg, et al.
Journal of Oncology|January 13, 2010
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck CancerGeorge Fountzilas, Anna Kalogera-Fountzila, Sophia Lambaki, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 26, 2025
Development of a preclinical model of ICU-associated sleep fragmentation and effects on pneumonia recovery in miceMahendra Damarla, Karthik Suresh, Linda Zheng, et al.
Journal of Clinical Medicine|August 6, 2020
Predicting the Role of DNA Polymerase β Alone or with <i>KRAS</i> Mutations in Advanced NSCLC Patients Receiving Platinum-Based ChemotherapyMaria Francesca Alvisi, Monica Ganzinelli, Helena Linardou, et al.
Cancer|September 25, 2020
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trialDarren R Feldman, Yasser Ged, Chung-Han Lee, et al.
Biomarkers in Medicine|July 28, 2017
RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world dataGeorge Kafatos, Daniela Niepel, Kimberley Lowe, et al.
JCO Precision Oncology|July 7, 2022
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell CarcinomaRitesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 16, 2024
Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertensionNicolas Philip, Xin Yun, Hongyang Pi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2021
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell CarcinomaJack P Gleeson, Ines Nikolovski, Renzo Dinatale, et al.
Pageof 7